Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 

QPP Measure #275

Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy

Percentage of patients with a diagnosis of inflammatory bowel disease (IBD) who had Hepatitis B Virus (HBV) status assessed and results interpreted prior to initiating anti-TNF (tumor necrosis factor) therapy.

Submission Methods: Registry
Measure Sets: Gastroenterology

There are no codes for this QPP measure yet (code lists for the current year may not have been established yet).

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.